1. Home
  2. FFNW vs NKTX Comparison

FFNW vs NKTX Comparison

Compare FFNW & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFNW
  • NKTX
  • Stock Information
  • Founded
  • FFNW 1923
  • NKTX 2015
  • Country
  • FFNW United States
  • NKTX United States
  • Employees
  • FFNW N/A
  • NKTX N/A
  • Industry
  • FFNW Banks
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFNW Finance
  • NKTX Health Care
  • Exchange
  • FFNW Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • FFNW 203.8M
  • NKTX 170.8M
  • IPO Year
  • FFNW N/A
  • NKTX 2020
  • Fundamental
  • Price
  • FFNW $21.43
  • NKTX $2.05
  • Analyst Decision
  • FFNW Hold
  • NKTX Strong Buy
  • Analyst Count
  • FFNW 2
  • NKTX 5
  • Target Price
  • FFNW $22.75
  • NKTX $15.20
  • AVG Volume (30 Days)
  • FFNW 17.6K
  • NKTX 853.6K
  • Earning Date
  • FFNW 01-28-2025
  • NKTX 03-20-2025
  • Dividend Yield
  • FFNW 1.21%
  • NKTX N/A
  • EPS Growth
  • FFNW N/A
  • NKTX N/A
  • EPS
  • FFNW 0.12
  • NKTX N/A
  • Revenue
  • FFNW $37,609,000.00
  • NKTX N/A
  • Revenue This Year
  • FFNW N/A
  • NKTX N/A
  • Revenue Next Year
  • FFNW $0.82
  • NKTX N/A
  • P/E Ratio
  • FFNW $183.59
  • NKTX N/A
  • Revenue Growth
  • FFNW N/A
  • NKTX N/A
  • 52 Week Low
  • FFNW $20.10
  • NKTX $1.96
  • 52 Week High
  • FFNW $23.50
  • NKTX $16.24
  • Technical
  • Relative Strength Index (RSI)
  • FFNW 50.18
  • NKTX 39.74
  • Support Level
  • FFNW $21.32
  • NKTX $1.96
  • Resistance Level
  • FFNW $21.61
  • NKTX $2.35
  • Average True Range (ATR)
  • FFNW 0.23
  • NKTX 0.15
  • MACD
  • FFNW 0.01
  • NKTX -0.00
  • Stochastic Oscillator
  • FFNW 54.43
  • NKTX 19.15

About FFNW First Financial Northwest Inc.

First Financial Northwest Inc is the holding company. The Bank's business consists predominantly of attracting deposits from the general public, combined with borrowing from the FHLB of Des Moines and raising funds in the wholesale market then utilizing these funds to originate one-to-four family residential, multifamily, commercial real estate, construction/land, business, and consumer loans. The Bank's strategic initiatives seek to diversify its loan portfolio and broaden growth opportunities with its current risk tolerance levels and asset/liability objectives.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: